2018 International Congress

Monday, October 8, 2018

1:15pm-2:45pm

Nursing diagnoses, outcomes and ICNP® interventions related to urinary dysfunction in Parkinson’s disease

M. Tosin, B. Oliveira (Santos-SP, Brazil)

Parkinson's Disease: Non-Motor Symptoms  ·  Hall 3FG

1:15pm-2:45pm

Objective and quantifiable assessment of sleep in patients with Parkinson’s disease using a wearable sensor

A. Mirelman, I. Hilell, N. Omer, A. Thaler, M. Kestenbaum, O. Assais, A. Orr-Urtreger, M. Brys, J. Cedarbaum, J. Hausdorff, N. Giladi (Tel Aviv, Israel)

Parkinson's Disease: Non-Motor Symptoms  ·  Hall 3FG

1:15pm-2:45pm

Objective intestinal dysfunction in REM sleep behaviour disorder

K. Knudsen, T. Fedorova, A. Hansen, M. Sommerauer, AM. Haase, M. Otto, K. Svendsen, K. Ostergaard, K. Krogh, P. Borghammer (Aarhus, Denmark)

Parkinson's Disease: Non-Motor Symptoms  ·  Hall 3FG

1:15pm-2:45pm

Odor identification in PD patients and controls in Estonian cohort

I. Kalju, T. Toomsoo, K. Vender (Tallinn, Estonia)

Parkinson's Disease: Non-Motor Symptoms  ·  Hall 3FG

1:15pm-2:45pm

Off-painfull state in Parkinson’s disease patients: A redflag of complulsive behavior. Data from a PET-FDG study

G. Albani, A. Cistaro, P. Fania, S. Margotti, V. Arena, A. Mauro (Verbania, Italy)

Parkinson's Disease: Non-Motor Symptoms  ·  Hall 3FG

1:15pm-2:45pm

Olfactory dysfunction, sleep disturbances, neuronal loss, and regional brain atrophy in an inducible mouse model of Alpha-Synucleinopathy

E. Brison, S. Zehntner, A. Zijdenbos, K. Luk, B. Bedell (Montreal, QC, Canada)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Hall 3FG

1:15pm-2:45pm

Olfactory Hallucinations as a Non-motor sign of Parkinson’s disease – A cross-sectional study amongst patients in a tertiary movement center

S. Chandra, M. Schiess, R. Mehanna (Houston, TX, USA)

Parkinson's Disease: Non-Motor Symptoms  ·  Hall 3FG

1:15pm-2:45pm

Olfactory impairment correlates strongly with limbic blood flow in patients with Parkinson’s disease

K. Ohta, T. Nakajima (Niigata, Japan)

Parkinson's Disease: Cognition  ·  Hall 3FG

1:15pm-2:45pm

Opposite effects of dopamine on specific NoGo perfomance in young and late onset Parkinson’s disease and the relationship to nigrostriatal degeneration

D. Kübler, H. Schroll, U. Scheller, R. Buchert, A. Kühn (Berlin, Germany)

Parkinson's Disease: Cognition  ·  Hall 3FG

1:15pm-2:45pm

Optimization of deep brain stimulation in STN among patients with Parkinson’s disease using a novel EEG-based tool

D. Sand, Z. Peremen, D. Haor, S. Israeli-Korn, D. Arkadir, M. Abu Snineh, Z. Israel, S. Hassin-Baer, R. Eitan, H. Bergman, A. Geva (Jerusalem and Herzlia, Israel)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Hall 3FG